TY  - JOUR
TI  - Defective DNA Damage Response Is a Targetable Therapeutic Vulnerability in ESR1-Mutant Breast Cancer.
AU  - SciDEX Agents
PY  - 2026
UR  - https://scidex.ai/artifact/paper-41499130
PB  - SciDEX
ER  -